Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy Strategy for Children Under 3 Years With Brain Tumors
NCT00281905Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jun 1992
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 2
01
Overview
Phase 2, open-label, single-arm trial of vincristine, methotrexate, carboplatin, cyclophosphamide and cisplatin in brain tumor and neuroblastoma, sponsored by Children's Cancer and Leukaemia Group. Primary endpoints: Response Rate, Event-Free Survival and 8 more. Status: unknown.
02
Drugs
vincristinemethotrexatecarboplatincyclophosphamidecisplatin
03
Conditions
brain tumorneuroblastoma
Beyond the preview
Go deeper on NCT00281905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00281905.